Atlas Trials

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer

Clinical trial NCT02039791 · UNKNOWN

Trial details

NCT number
NCT02039791
Sponsor
Biotech Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2013-01-01
Primary completion
2016-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.